Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stress

Cardiovascular Research

Volumn 92, Issue 3, 2011, Pages 375-384

  Jerkic, Mirjana ^a,b   Kabir, Mohammed G ^b   Davies, Adrienne ^a   Yu, Lisa X ^a,c   McIntyre, Brendan A S ^a   Husain, Nasir W ^a   Enomoto, Masahiro ^a   Sotov, Valentin ^a,c   Husain, Mansoor ^b,d   Henkelman, Mark ^a,c   Belik, Jaques ^a,b   Letarte, Michelle ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Anti oxidant; Endothelial receptors; Nitric oxide; Oxygen radicals; Pulmonary hypertension

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; TEMPOL;

ARTERIAL WALL THICKNESS; ARTICLE; CONTROLLED STUDY; GENE DELETION; HEART RIGHT VENTRICLE HYPERTROPHY; MOUSE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE;

ACTIVIN RECEPTORS, TYPE I; AGE FACTORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; ARTERIOLES; BLOOD PRESSURE; CATALASE; CYCLIC N-OXIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; HETEROZYGOTE; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; LUNG; MICE; MICE, KNOCKOUT; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PULMONARY ARTERY; REACTIVE OXYGEN SPECIES; SPIN LABELS; SUPEROXIDE DISMUTASE; VASODILATION; VASODILATOR AGENTS; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR PRESSURE;

EID: 81055125053     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr232     Document Type: Article

References (40)

1. Berg JN, Gallione CJ, Stenzel TT, Johnson DW, Allen WP, Schwartz CE et al. The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet 1997;61:60-67. (Pubitemid 27323324)
2. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994;8:345-351.
3. Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet 2009;17:860-871.
4. Pece N, Vera S, Cymerman U, White RI Jr, Wrana JL, Letarte M. Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. J Clin Invest 1997;100:2568-2579. (Pubitemid 27514897)
5. Abdalla SA, Letarte M. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet 2006;43:97-110. (Pubitemid 43262964)
6. Blanco FJ, Santibanez JF, Guerrero-Esteo M, Langa C, Vary CP, Bernabeu C. Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex. J Cell Physiol 2005;204:574-584. (Pubitemid 40934653)
7. David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 2007;109:1953-1961. (Pubitemid 46348192)
8. Scharpfenecker M, van Dinther M, Liu Z, van Bezooijen RL, Zhao Q, Pukac L et al. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 2007;120:964-972. (Pubitemid 46638511)
9. Trembath RC, Thomson JR, Machado RD, Morgan NV, Atkinson C, Winship I et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2001;345:325-334. (Pubitemid 32703235)
10. Harrison RE, Flanagan JA, Sankelo M, Abdalla SA, Rowell J, Machado RD et al. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia. J Med Genet 2003;40: 865-871. (Pubitemid 38117534)
11. Harrison RE, Berger R, Haworth SG, Tulloh R, Mache CJ, Morrell NW et al. Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood. Circulation 2005;111:435-441. (Pubitemid 40204427)
12. Mache CJ, Gamillscheg A, Popper HH, Haworth SG. Early-life pulmonary arterial hypertension with subsequent development of diffuse pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia type 1. Thorax 2008;63:85-86.
13. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54: S43-S54.
14. Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA 3rd, Loyd JE et al. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 2000;26:81-84.
15. Machado RD, Aldred MA, James V, Harrison RE, Patel B, Schwalbe EC et al. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat 2006;27:121-132. (Pubitemid 43238027)
16. Upton PD, Davies RJ, Trembath RC, Morrell NW. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells. J Biol Chem 2009;284:15794-15804.
17. Megalou AJ, Glava C, Oikonomidis DL, Vilaeti A, Agelaki MG, Baltogiannis GG et al. Transforming growth factor-beta inhibition attenuates pulmonary arterial hypertension in rats. Int J Clin Exp Med 2010;3:332-340.
18. Toporsian M, Gros R, Kabir MG, Vera S, Govindaraju K, Eidelman DH et al. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 2005;96:684-692. (Pubitemid 40478336)
19. Toporsian M, Jerkic M, Zhou YQ, Kabir MG, Yu LX, McIntyre BA et al. Spontaneous adult-onset pulmonary arterial hypertension attributable to increased endothelial oxidative stress in a murine model of hereditary hemorrhagic telangiectasia. Arterioscler Thromb Vasc Biol 2010;30:509-517.
20. Seki T, Yun J, Oh SP. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res 2003;93:682-689. (Pubitemid 37222165)
21. Belik J, Jerkic M, McIntyre BA, Pan J, Leen J, Yu LX et al. Age-dependent endothelial nitric oxide synthase uncoupling in pulmonary arteries of endoglin heterozygous mice. Am J Physiol Lung Cell Mol Physiol 2009;297:L1170-L1178.
22. Copland IB, Reynaud D, Pace-Asciak C, Post M. Mechanotransduction of stretchinduced prostanoid release by fetal lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2006;291:L487-L495. (Pubitemid 44343726)
23. Jerkic M, Rivas-Elena JV, Prieto M, Carron R, Sanz-Rodriguez F, Perez-Barriocanal F et al. Endoglin regulates nitric oxide-dependent vasodilatation. Faseb J 2004;18: 609-611.
24. Ruan CH, Dixon RA, Willerson JT, Ruan KH. Prostacyclin therapy for pulmonary arterial hypertension. Tex Heart Inst J 2010;37:391-399.
25. Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54: S20-S31.
26. Burhop KE, Selig WM, Malik AB. Monohydroxyeicosatetraenoic acids (5-HETE and 15-HETE) induce pulmonary vasoconstriction and edema. Circ Res 1988;62:687-698.
27. Stephenson AH, Sprague RS, Lonigro AJ. 5,6-Epoxyeicosatrienoic acid reduces increases in pulmonary vascular resistance in the dog. Am J Physiol 1998;275: H100-H109.
28. Chen CA, Druhan LJ, Varadharaj S, Chen YR, Zweier JL. Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme. J Biol Chem 2008;283:27038-27047.
29. Demarco VG, Whaley-Connell AT, Sowers JR, Habibi J, Dellsperger KC. Contribution of oxidative stress to pulmonary arterial hypertension. World J Cardiol 2010;2: 316-324.
30. Edwards DH, Li Y, Griffith TM. Hydrogen peroxide potentiates the EDHF phenomenon by promoting endothelial Ca2+ mobilization. Arterioscler Thromb Vasc Biol 2008; 28:1774-1781.
31. Buscarini E, Plauchu H, Garcia Tsao G, White RI Jr, Sabba C, Miller F et al. Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations. Liver Int 2006;26:1040-1046. (Pubitemid 44541744)
32. Xu S, Touyz RM. Reactive oxygen species and vascular remodelling in hypertension: still alive. Can J Cardiol 2006;22:947-951.
33. Wajima T, Shimizu S, Hiroi T, Ishii M, Kiuchi Y. Reduction of myocardial infarct size by tetrahydrobiopterin: possible involvement of mitochondrial katp channels activation through nitric oxide production. J Cardiovasc Pharmacol 2006;47:243-249. (Pubitemid 44384063)
34. Wilcox CS, Pearlman A. Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol Rev 2008;60:418-469.
35. Galie N, Palazzini M, Manes A. Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. Eur Heart J 2010;31:2080-2086.
36. Beppu H, Ichinose F, Kawai N, Jones RC, Yu PB, Zapol WM et al. BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia. Am J Physiol Lung Cell Mol Physiol 2004; 287:L1241-L1247. (Pubitemid 39507203)
37. Song Y, Jones JE, Beppu H, Keaney JF Jr, Loscalzo J, Zhang YY. Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice. Circulation 2005; 112:553-562. (Pubitemid 41060796)
38. Long L, MacLean MR, Jeffery TK, Morecroft I, Yang X, Rudarakanchana N et al. Serotonin increases susceptibility to pulmonary hypertension in bmpr2-deficient mice. Circ Res 2006;98:818-827.
39. West J, Fagan K, SteudelW, Fouty B, Lane K, Harral J et al. Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle. Circ Res 2004;94:1109-1114. (Pubitemid 38579706)
40. Hong KH, Lee YJ, Lee E, Park SO, Han C, Beppu H et al. Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension. Circulation 2008;118:722-730.